RxDoctor Payments Data

Sandreka Jones, DPM

Podiatrist · New Orleans, LANPI 1932637485

Payments from drug & device makers

What this record shows

13 manufacturers reported payments, led by Stryker at 55.5% of the total. 2025 is the largest year on record at $2,746, 5.6 times the $486 reported in 2019.

$6,439in general payments, 2019–2025

Across 84 payments — averaging $76.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Treace Medical Concepts, Inc.$2K
  • Smith+Nephew$427
  • Integra Lifesciences Corporation$223
  • Kerecis Limited$175
  • Mimedx Group, Inc.$109
  • plus $318 from 7 others

What the payments were for

  • Travel & lodging$2,95046%
  • Food & beverage$3,48954%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,439 in reported general payments places this provider in the 75th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$7,555
Medicare patients
67
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox88$3,048
Ketoconazole70$2,279
Diclofenac Sodium25$1,492
Gabapentin86$934
Terbinafine Hcl28$507
Ibuprofen41$205
Methylprednisolone28$186
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$172
Mupirocin18$114
Cephalexin11$99
Tramadol Hcl13$37

Paid to pharmacies, not to this prescriber.

Other podiatrist in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →